Editorials

Vetting new technologies

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7056.508 (Published 31 August 1996) Cite this as: BMJ 1996;313:508
  1. Trevor A Sheldon,
  2. Alex Faulkner
  1. NHS Centre for Reviews and Dissemination, University of York, York YO1 5DD
  2. Research associate Department of Social Medicine, University of Bristol, Bristol BS8 2PR

    Those whose efficacy and safety have not been established will now be registered and evaluated

    While it is compulsory to evaluate drugs before their widespread use is permitted, other medical interventions are not subject to the same constraints. This has allowed a tidal wave of new health care technologies, which have diffused through health care systems before (or in spite of) proper evaluation to establish safety, effectiveness, or return on investment. This haphazard and uncontrolled adoption of procedures was brought to public attention most recently by the unseemly haste with which laparoscopic surgical techniques were adopted, the associated cases of severe complications,1 and the increased costs.2 The routine use of ultrasound during early pregnancy despite little evidence of benefit3 and the proliferation of unevaluated hip prostheses4 are other examples of the way in which health technologies or their modification can spread without sufficient caution. Highly …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe